Overexpressed SNHG15 could promote the occurrence of drug resistance in tumors and reduce the sensitivity of cancer cells to chemotherapy drugs, suggesting its potential as a crucial prognostic factor to predict tumor drug resistance. Here, SNHG15 is linked to neoplasm.